XML 54 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation (Tables)
12 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award Total share-based compensation included as a component of selling, general and administrative expenses in our Consolidated Income Statements was as follows:
 Fiscal Year Ended June 30,
 202220212020
 (in thousands)
Share-based compensation related to:
Equity classified stock options$1,848 $1,332 $508 
Equity classified restricted stock9,815 6,707 4,970 
Total share-based compensation$11,663 $8,039 $5,478 
Weighted Average Assumptions for the Options Granted During the Following Fiscal Years
The Company used the following weighted-average assumptions for the options granted in fiscal year ended June 30, 2021:

 Fiscal Year Ended June 30,
 2021
Expected term5 years
Expected volatility42.78%
Risk-free interest rate0.36%
Dividend yield0.00%
Weighted-average fair value per option$9.01
Stock Option Plans
A summary of activity under our stock option plans is presented below:

 Fiscal Year Ended June 30, 2022
 OptionsWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Life
Aggregate
Intrinsic
Value
Outstanding, beginning of year1,235,569 $31.84 
Granted during the period— — 
Exercised during the period(78,126)29.47 
Canceled, forfeited, or expired during the period(34,344)24.50 
Outstanding, end of year1,123,099 32.23 5.77$3,343,205 
Vested and expected to vest at June 30, 20221,119,804 32.26 5.76$3,320,639 
Exercisable, end of year738,461 $35.92 4.40$— 
Unvested Shares
A summary of the status of the Company’s shares subject to unvested options is presented below:
 Fiscal Year Ended June 30, 2022
 OptionsWeighted Average Exercise PriceWeighted Average
Grant Date 
Fair Value
Unvested, beginning of year633,582 $25.10 $9.02 
Granted— — — 
Vested(214,600)25.11 9.03 
Canceled or forfeited(34,344)24.50 8.31 
Unvested, end of year384,638 $25.16 $9.08 
Stock Options Outstanding The following table summarizes information about stock options outstanding and exercisable as of June 30, 2022:
 Options OutstandingOptions Exercisable
Range of Exercise PricesShares
  Outstanding
Weighted
Average
Remaining
  Contractual Life
Weighted Average
Exercise
Price
Number ExercisableWeighted Average
Exercise
Price
$22.27 - $26.38
418,853 8.3824.52 128,480 24.55 
$26.38 - $30.49
142,825 8.4027.14 48,560 27.14 
$30.49 - $34.60
73,303 5.4634.06 73,303 34.06 
$34.60 - $38.71
208,669 3.8437.71 208,669 37.71 
$38.71 - $42.82
279,449 2.0241.82 279,449 41.83 
1,123,099 5.77$32.23 738,461 $35.92 
Restricted Stock Outstanding During the fiscal year ended June 30, 2022, the Company granted 381,204 shares of restricted stock to employees and non-employee directors, all of which were issued in the form of RSUs:
 Fiscal Year Ended June 30, 2022
 Shares
granted
Date grantedGrant date
fair value
Vesting period
Employees
Certain employees based on performance255,438 August 27, 2021$36.05 
Annually over 4 years
Certain employees based on performance36,927 August 27, 2021$36.05 
Annually over 3 years
Certain employees based on performance36,931 August 27, 2021$41.26 
Annually over 3 years
Certain employees based upon hire8,671 September 1, 2021$34.60 
Annually over 4 years
Certain employees based on performance3,041 December 1, 2021$30.46 
Annually over 4 years
Certain employees based on performance3,020 March 1, 2022$35.51 
Annually over 4 years
Certain employees based on performance1,294 June 1, 2022$38.73 
Annually over 4 years
Certain employees based on hire2,582 June 1, 2022$38.73 
Annually over 4 years
Non-Employee Directors
Certain Directors33,300 August 27, 2021$36.05 
6 months

A summary of the status of the Company’s outstanding restricted stock is presented below:

 Fiscal Year Ended June 30, 2022
 SharesWeighted-Average
Grant Date Fair
Value
Outstanding, beginning of year537,983 $27.99 
Granted during the period381,204 36.47 
Vested during the period(237,943)30.54 
Cancelled, forfeited, or expired during the period(41,902)28.93 
Outstanding, end of year639,342 $32.04